Inflammatory Response Modulation

Fetal bovine serum (FBS) and penicillin/streptomycin were obtained from Thermo Fisher Scientific (MA, USA). Griess Reagent (1% sulfanilamide in 5% H 3 PO 4 , 0.1% N-(1-naphthyl)-ethylenediamine dihydrochloride), LPS from E. coli 0128:B18, and dexamethasone were purchased from Sigma-Aldrich (MO, USA).

Partial Protocol Preview
This section provides a glimpse into the protocol.
The remaining content is hidden due to licensing restrictions, but the full text is available at the following link: Access Free Full Text.

Hwang S., Kim J.S., Na G.K., Lee H., Yun B., Park J., Han S., Park M., Lee W., Choi K., & Park J.U. (2024). Characterization of the Anti-Inflammatory, Immune Response, and Anti-Bacterial Properties of the Polar Extracts of Indigenous Korean Plants. Natural Product Communications, 19(7).

Publication 2024

Corresponding Organization : National Institute of Biological Resources

Top 5 similar protocols

Variable analysis

independent variables

Fetal bovine serum (FBS)
Penicillin/streptomycin
Griess Reagent (1% sulfanilamide in 5% H3PO4, 0.1% N-(1-naphthyl)-ethylenediamine dihydrochloride)
LPS from E. coli 0128:B18
Dexamethasone

dependent variables

Not explicitly mentioned

control variables

Not explicitly mentioned

positive controls

Not explicitly mentioned

negative controls

Not explicitly mentioned

Annotations

Based on most similar protocols

Etiam vel ipsum. Morbi facilisis vestibulum nisl. Praesent cursus laoreet felis. Integer adipiscing pretium orci. Nulla facilisi. Quisque posuere bibendum purus. Nulla quam mauris, cursus eget, convallis ac, molestie non, enim. Aliquam congue. Quisque sagittis nonummy sapien. Proin molestie sem vitae urna. Maecenas lorem.

As authors may omit details in methods from publication, our AI will look for missing critical information across the 5 most similar protocols.

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Revolutionizing how scientists
search and build protocols!